Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009)

International Journal of Cancer

Volumn 134, Issue 2, 2014, Pages 487-492

  Rodrigo, Juan P ^a   Heideman, Daniëlle A M ^b   García Pedrero, Juana M ^a   Fresno, Manuel F ^a   Brakenhoff, Ruud H ^b   Díaz Molina, Juan P ^a   Snijders, Peter J F ^b   Hermsen, Mario A ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

human papillomavirus; immunohistochemistry; in situ hybridization; oropharyngeal squamous cell carcinoma; PCR

Indexed keywords

PROTEIN P16; PROTEIN P53; VIRUS DNA;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPING TECHNIQUE; GEOGRAPHIC DISTRIBUTION; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; OROPHARYNX SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; SPAIN; SQUAMOUS CELL CARCINOMA; TREND STUDY; TUMOR DIFFERENTIATION; VIRUS DETECTION;

HUMAN PAPILLOMAVIRUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; PCR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SPAIN; TIME FACTORS; TISSUE ARRAY ANALYSIS;

EID: 84887482992     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28355     Document Type: Article

References (24)

1. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-9. (Pubitemid 351264356)
2. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-9.
3. de Camargo CM, de Souza DL, Curado MP,. International incidence of oropharyngeal cancer: a population-based study. Oral Oncol 2012; 48: 484-90.
4. de Souza DL, de Camargo Cancela M, Pérez MM, et al. Trends in the incidence of oral cavity and oropharyngeal cancers in Spain. Head Neck 2012; 34: 649-54.
5. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr, accessed on February 17, 2013.
6. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
7. Herrero R, Castellsagué X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-83. (Pubitemid 38008900)
8. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75. (Pubitemid 40270113)
9. Ribeiro KB, Levi JE, Pawlita M, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 2011; 40: 489-502.
10. Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011; 17: 6262-71.
11. Rietbergen MM, Leemans CR, Bloemena E, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013; 132: 1565-71.
12. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viralinduced carcinoma? Int J Cancer 2009; 125: 362-6.
13. De Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
14. Díaz-Molina JP, Llorente JL, Vivanco B, et al. Wnt-pathway activation in intestinal-type sinonasal adenocarcinoma. Rhinology 2011; 49: 593-9.
15. Lõpez F, Llorente JL, Oviedo CM, et al. Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma. Cancer 2012; 118: 1818-26.
16. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-72. (Pubitemid 350022416)
17. Pannone G, Rodolico V, Santoro A, et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer 2012; 7: 4.
18. El-Naggar AK, Westra WH,. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 2012; 34: 459-61.
19. Alvarez Alvarez I, Sanchez Lazo P, Ramos Gonzalez S, et al. Using polymerase chain reaction to human papillomavirus in oral and pharyngolaryngeal carcinomas. Am J Otolaryngol 1997; 18: 375-81. (Pubitemid 27495800)
20. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
21. Psyrri A, Cohen E,. Oropharyngeal cancer: clinical implications of the HPV connection. Ann Oncol 2011; 22: 997-9.
22. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-6. (Pubitemid 46631302)
23. O'Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013; 31: 543-50.
24. Quon H, Forastiere AA,. Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? J Clin Oncol 2013; 31: 520-2.